Compare Msci Inc (MSCI) vs Vir Biotechnology Inc. Common Stock (VIR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Msci Inc vs Vir Biotechnology Inc. Common Stock — how do they compare? Msci Inc trades at $561.1 (market cap $40.75B), while Vir Biotechnology Inc. Common Stock trades at $10.49 (market cap $1.76B). The key difference: Msci Inc is far larger — about 23.2× Vir Biotechnology Inc. Common Stock's market cap, and Msci Inc pays a 1.46% dividend while Vir Biotechnology Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Msci Inc for 83 Days and Vir Biotechnology Inc. Common Stock for 0 Days on average.
| MSCI | VIR | |
|---|---|---|
Market Cap | $40.75B | $1.76B |
Volume | 548,630 | 2,764,948 |
Sector | Financials | Health |
52-Week High | $643.83 | $11.78 |
52-Week Low | $511.84 | $5.12 |
Typical Hold Time | 83 Days | 0 Days |
Enterprise Value | $46.92B | $1.32B |
Dividend Yield | 1.46% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
MSCI trades at $560.82, down 1.27% on the day, with a bullish technical signal and strong fundamental performance. Revenue grew to $3.13B in 2025, with a net income margin of 40.73%. The company recently completed the acquisition of First Street, expanding its climate risk analytics offerings. Analyst consensus is strongly bullish with a $701.71 price target, indicating significant upside potential from current levels.
The outlook for MSCI remains positive due to consistent earnings beats, high profitability margins, and strategic acquisitions. Key risks include high valuation multiples and substantial long-term debt of $4.51B. Institutional sentiment supports growth, but investors should monitor execution of integration strategies and macroeconomic factors affecting financial markets.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Msci Inc
MSCI describes its mission as enabling investors to build better portfolios for a better world. MSCI's largest and most profitable segment is its index segment, where it provides benchmarking to asset managers and asset owners. In addition, it boasts over $1 trillion in ETF assets linked to MSCI indexes. The MSCI analytics segment provides portfolio management and risk management analytics software to asset managers and asset owners. MSCI's all other segment was broken out into ESG and climate and private assets segments in 2021. In ESG and climate, MSCI provides ESG data to the investment industry. In the private assets side, MSCI provides real restate reporting, market data, benchmarking, and analytics to investors and real estate managers.
Read more on MSCI →About Vir Biotechnology Inc. Common Stock
Vir Biotechnology, Inc. is a US clinical-stage biopharmaceutical company that develops monoclonal antibody-based medicines to treat and prevent serious infectious diseases.
Read more on VIR →
